regenerative medicine/stem cell therapy” indiana stem … annual... · derived from human embryos...
TRANSCRIPT
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
ldquoRegenerative MedicineStem Cell
Therapyrdquo
FORMED 2010
DR MARK BERMAN COSMETIC SURGEON
DR ELLIOT LANDER UROLOGIST
FIRST MULTISPECIALTY CENTER
FIRST TO STUDY ADIPOSE DERIVED STEM CELLS UNDER IRB APPROVED RESEARCH PROTOCOLS
DEVELOPED CUSTOMIZED EQUIPMENT
DEVELOPMENT OF ldquoCELL SURGICALrdquo CONCEPT
FIRST TO FORM AN INTERNATIONAL RESEARCH NETWORK
Uses stem cells and growth factors
Repair or replace tissue or lost organ function due to
damage or congenital defects
Create living functional tissues
Stimulate previously irreparable organs to heal
themselves
A cell that can proliferate (replicate)
A cell that can differentiate (turn into other specific
cells or tissues)
EMBRYONIC
ADULT MESENCHYMAL
Can turn into any type of tissue in the whole body
Moral andor ethical issues
Derived from human embryos aborted or left over
from In Vitro Fertilization
Different DNA from host
Can form tumor cells (teratomas)
Found all over the body
Bone marrow produces continual flow of ldquomesenchymalrdquo stem cells
Fat has abundant source of mesenchymal stem cells
Multi-potent
No moral or ethical issue
Can Form BoneCartilageMuscleNerve tissue Blood vesselsConnective tissue Fat
Polypetide (protein) signaling molecules
Bone marrow (120000 cells)
Fat (aka adipose derived regenerative stem cells)
Others (cord organs)-low numbers
Mesenchyme stem cells decline with age
ALLOGENEIC- other humans
AUTOLOGOUS- (comes from your own body) so has same DNA as host and canrsquot be rejected lower risk of bacterial or viral infection
Dormant if no tissue damage or injury
They respond to tissue injury inflammation
degeneration or cell death
Tissue damage-homing properties
Cells may turn into needed tissue
Cells may provide messaging through Growth
Factors (eg cytokines) to repair damaged cells
Stem cell BIOAVAILABILITY- dormant cells
made available to damaged tissue
When additional stem cells are added to injured
areas in large numbers they can effect therapeutic
changes
Can exert local and systemic changes
New equipment and enzymes
Adipose (fat) derived stem cells are easy to harvest
Safe ndash under local anesthesia
Safe ndash Autologous (your own cells)
Abundant numbers of cells
Procedure takes 3 hours total
PART OF FAT RICH IN ADULT MESENCHYMAL STEM CELLS AND NATURAL GROWTH FACTORS
WHAT WE DEPLOY AT CALIFORNIA STEM CELL TREATMENT CENTERreg
Harvest fat under local anesthesia
Centrifuge to concentrate the fat
Add an enzyme to digest collagen tissue that binds
fat cells and stem cells
Remove stem cells (stromal vascular fraction) from bottom of syringe ndash ldquoclosed (sterile) techniquerdquo
SVF PROCUREMENT TAKES 80 MINUTES
Stemprogenitor cells
Direct injections into affected arthritic joints
Injection into difficult areas via fluoroscopy
Intravenous injection to affect systemic changes
Injection into spinal fluid or other remote areas
Directly into arteries of body or brain
Directly into soft tissues showing damage
SVF IS REGENERATIVE
SVF IS ANTI-INFLAMMATORY
SVF IS IMMUNO-MODULATORY
Orthopedics
Degenerative Diseases
Cardio-Pulmonary Diseases
Autoimmune Diseases
Urology
Neurology
Cosmetic Surgery
Spinal disk Arthritis and Chronic back or neck pain
Ankle
Hip
Knee
Tendons Ligaments Sports Injuries
Elbow Wrist
Shoulder
Prior to SVF deployment4 months after SVF deployment
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
FORMED 2010
DR MARK BERMAN COSMETIC SURGEON
DR ELLIOT LANDER UROLOGIST
FIRST MULTISPECIALTY CENTER
FIRST TO STUDY ADIPOSE DERIVED STEM CELLS UNDER IRB APPROVED RESEARCH PROTOCOLS
DEVELOPED CUSTOMIZED EQUIPMENT
DEVELOPMENT OF ldquoCELL SURGICALrdquo CONCEPT
FIRST TO FORM AN INTERNATIONAL RESEARCH NETWORK
Uses stem cells and growth factors
Repair or replace tissue or lost organ function due to
damage or congenital defects
Create living functional tissues
Stimulate previously irreparable organs to heal
themselves
A cell that can proliferate (replicate)
A cell that can differentiate (turn into other specific
cells or tissues)
EMBRYONIC
ADULT MESENCHYMAL
Can turn into any type of tissue in the whole body
Moral andor ethical issues
Derived from human embryos aborted or left over
from In Vitro Fertilization
Different DNA from host
Can form tumor cells (teratomas)
Found all over the body
Bone marrow produces continual flow of ldquomesenchymalrdquo stem cells
Fat has abundant source of mesenchymal stem cells
Multi-potent
No moral or ethical issue
Can Form BoneCartilageMuscleNerve tissue Blood vesselsConnective tissue Fat
Polypetide (protein) signaling molecules
Bone marrow (120000 cells)
Fat (aka adipose derived regenerative stem cells)
Others (cord organs)-low numbers
Mesenchyme stem cells decline with age
ALLOGENEIC- other humans
AUTOLOGOUS- (comes from your own body) so has same DNA as host and canrsquot be rejected lower risk of bacterial or viral infection
Dormant if no tissue damage or injury
They respond to tissue injury inflammation
degeneration or cell death
Tissue damage-homing properties
Cells may turn into needed tissue
Cells may provide messaging through Growth
Factors (eg cytokines) to repair damaged cells
Stem cell BIOAVAILABILITY- dormant cells
made available to damaged tissue
When additional stem cells are added to injured
areas in large numbers they can effect therapeutic
changes
Can exert local and systemic changes
New equipment and enzymes
Adipose (fat) derived stem cells are easy to harvest
Safe ndash under local anesthesia
Safe ndash Autologous (your own cells)
Abundant numbers of cells
Procedure takes 3 hours total
PART OF FAT RICH IN ADULT MESENCHYMAL STEM CELLS AND NATURAL GROWTH FACTORS
WHAT WE DEPLOY AT CALIFORNIA STEM CELL TREATMENT CENTERreg
Harvest fat under local anesthesia
Centrifuge to concentrate the fat
Add an enzyme to digest collagen tissue that binds
fat cells and stem cells
Remove stem cells (stromal vascular fraction) from bottom of syringe ndash ldquoclosed (sterile) techniquerdquo
SVF PROCUREMENT TAKES 80 MINUTES
Stemprogenitor cells
Direct injections into affected arthritic joints
Injection into difficult areas via fluoroscopy
Intravenous injection to affect systemic changes
Injection into spinal fluid or other remote areas
Directly into arteries of body or brain
Directly into soft tissues showing damage
SVF IS REGENERATIVE
SVF IS ANTI-INFLAMMATORY
SVF IS IMMUNO-MODULATORY
Orthopedics
Degenerative Diseases
Cardio-Pulmonary Diseases
Autoimmune Diseases
Urology
Neurology
Cosmetic Surgery
Spinal disk Arthritis and Chronic back or neck pain
Ankle
Hip
Knee
Tendons Ligaments Sports Injuries
Elbow Wrist
Shoulder
Prior to SVF deployment4 months after SVF deployment
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Uses stem cells and growth factors
Repair or replace tissue or lost organ function due to
damage or congenital defects
Create living functional tissues
Stimulate previously irreparable organs to heal
themselves
A cell that can proliferate (replicate)
A cell that can differentiate (turn into other specific
cells or tissues)
EMBRYONIC
ADULT MESENCHYMAL
Can turn into any type of tissue in the whole body
Moral andor ethical issues
Derived from human embryos aborted or left over
from In Vitro Fertilization
Different DNA from host
Can form tumor cells (teratomas)
Found all over the body
Bone marrow produces continual flow of ldquomesenchymalrdquo stem cells
Fat has abundant source of mesenchymal stem cells
Multi-potent
No moral or ethical issue
Can Form BoneCartilageMuscleNerve tissue Blood vesselsConnective tissue Fat
Polypetide (protein) signaling molecules
Bone marrow (120000 cells)
Fat (aka adipose derived regenerative stem cells)
Others (cord organs)-low numbers
Mesenchyme stem cells decline with age
ALLOGENEIC- other humans
AUTOLOGOUS- (comes from your own body) so has same DNA as host and canrsquot be rejected lower risk of bacterial or viral infection
Dormant if no tissue damage or injury
They respond to tissue injury inflammation
degeneration or cell death
Tissue damage-homing properties
Cells may turn into needed tissue
Cells may provide messaging through Growth
Factors (eg cytokines) to repair damaged cells
Stem cell BIOAVAILABILITY- dormant cells
made available to damaged tissue
When additional stem cells are added to injured
areas in large numbers they can effect therapeutic
changes
Can exert local and systemic changes
New equipment and enzymes
Adipose (fat) derived stem cells are easy to harvest
Safe ndash under local anesthesia
Safe ndash Autologous (your own cells)
Abundant numbers of cells
Procedure takes 3 hours total
PART OF FAT RICH IN ADULT MESENCHYMAL STEM CELLS AND NATURAL GROWTH FACTORS
WHAT WE DEPLOY AT CALIFORNIA STEM CELL TREATMENT CENTERreg
Harvest fat under local anesthesia
Centrifuge to concentrate the fat
Add an enzyme to digest collagen tissue that binds
fat cells and stem cells
Remove stem cells (stromal vascular fraction) from bottom of syringe ndash ldquoclosed (sterile) techniquerdquo
SVF PROCUREMENT TAKES 80 MINUTES
Stemprogenitor cells
Direct injections into affected arthritic joints
Injection into difficult areas via fluoroscopy
Intravenous injection to affect systemic changes
Injection into spinal fluid or other remote areas
Directly into arteries of body or brain
Directly into soft tissues showing damage
SVF IS REGENERATIVE
SVF IS ANTI-INFLAMMATORY
SVF IS IMMUNO-MODULATORY
Orthopedics
Degenerative Diseases
Cardio-Pulmonary Diseases
Autoimmune Diseases
Urology
Neurology
Cosmetic Surgery
Spinal disk Arthritis and Chronic back or neck pain
Ankle
Hip
Knee
Tendons Ligaments Sports Injuries
Elbow Wrist
Shoulder
Prior to SVF deployment4 months after SVF deployment
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
A cell that can proliferate (replicate)
A cell that can differentiate (turn into other specific
cells or tissues)
EMBRYONIC
ADULT MESENCHYMAL
Can turn into any type of tissue in the whole body
Moral andor ethical issues
Derived from human embryos aborted or left over
from In Vitro Fertilization
Different DNA from host
Can form tumor cells (teratomas)
Found all over the body
Bone marrow produces continual flow of ldquomesenchymalrdquo stem cells
Fat has abundant source of mesenchymal stem cells
Multi-potent
No moral or ethical issue
Can Form BoneCartilageMuscleNerve tissue Blood vesselsConnective tissue Fat
Polypetide (protein) signaling molecules
Bone marrow (120000 cells)
Fat (aka adipose derived regenerative stem cells)
Others (cord organs)-low numbers
Mesenchyme stem cells decline with age
ALLOGENEIC- other humans
AUTOLOGOUS- (comes from your own body) so has same DNA as host and canrsquot be rejected lower risk of bacterial or viral infection
Dormant if no tissue damage or injury
They respond to tissue injury inflammation
degeneration or cell death
Tissue damage-homing properties
Cells may turn into needed tissue
Cells may provide messaging through Growth
Factors (eg cytokines) to repair damaged cells
Stem cell BIOAVAILABILITY- dormant cells
made available to damaged tissue
When additional stem cells are added to injured
areas in large numbers they can effect therapeutic
changes
Can exert local and systemic changes
New equipment and enzymes
Adipose (fat) derived stem cells are easy to harvest
Safe ndash under local anesthesia
Safe ndash Autologous (your own cells)
Abundant numbers of cells
Procedure takes 3 hours total
PART OF FAT RICH IN ADULT MESENCHYMAL STEM CELLS AND NATURAL GROWTH FACTORS
WHAT WE DEPLOY AT CALIFORNIA STEM CELL TREATMENT CENTERreg
Harvest fat under local anesthesia
Centrifuge to concentrate the fat
Add an enzyme to digest collagen tissue that binds
fat cells and stem cells
Remove stem cells (stromal vascular fraction) from bottom of syringe ndash ldquoclosed (sterile) techniquerdquo
SVF PROCUREMENT TAKES 80 MINUTES
Stemprogenitor cells
Direct injections into affected arthritic joints
Injection into difficult areas via fluoroscopy
Intravenous injection to affect systemic changes
Injection into spinal fluid or other remote areas
Directly into arteries of body or brain
Directly into soft tissues showing damage
SVF IS REGENERATIVE
SVF IS ANTI-INFLAMMATORY
SVF IS IMMUNO-MODULATORY
Orthopedics
Degenerative Diseases
Cardio-Pulmonary Diseases
Autoimmune Diseases
Urology
Neurology
Cosmetic Surgery
Spinal disk Arthritis and Chronic back or neck pain
Ankle
Hip
Knee
Tendons Ligaments Sports Injuries
Elbow Wrist
Shoulder
Prior to SVF deployment4 months after SVF deployment
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
EMBRYONIC
ADULT MESENCHYMAL
Can turn into any type of tissue in the whole body
Moral andor ethical issues
Derived from human embryos aborted or left over
from In Vitro Fertilization
Different DNA from host
Can form tumor cells (teratomas)
Found all over the body
Bone marrow produces continual flow of ldquomesenchymalrdquo stem cells
Fat has abundant source of mesenchymal stem cells
Multi-potent
No moral or ethical issue
Can Form BoneCartilageMuscleNerve tissue Blood vesselsConnective tissue Fat
Polypetide (protein) signaling molecules
Bone marrow (120000 cells)
Fat (aka adipose derived regenerative stem cells)
Others (cord organs)-low numbers
Mesenchyme stem cells decline with age
ALLOGENEIC- other humans
AUTOLOGOUS- (comes from your own body) so has same DNA as host and canrsquot be rejected lower risk of bacterial or viral infection
Dormant if no tissue damage or injury
They respond to tissue injury inflammation
degeneration or cell death
Tissue damage-homing properties
Cells may turn into needed tissue
Cells may provide messaging through Growth
Factors (eg cytokines) to repair damaged cells
Stem cell BIOAVAILABILITY- dormant cells
made available to damaged tissue
When additional stem cells are added to injured
areas in large numbers they can effect therapeutic
changes
Can exert local and systemic changes
New equipment and enzymes
Adipose (fat) derived stem cells are easy to harvest
Safe ndash under local anesthesia
Safe ndash Autologous (your own cells)
Abundant numbers of cells
Procedure takes 3 hours total
PART OF FAT RICH IN ADULT MESENCHYMAL STEM CELLS AND NATURAL GROWTH FACTORS
WHAT WE DEPLOY AT CALIFORNIA STEM CELL TREATMENT CENTERreg
Harvest fat under local anesthesia
Centrifuge to concentrate the fat
Add an enzyme to digest collagen tissue that binds
fat cells and stem cells
Remove stem cells (stromal vascular fraction) from bottom of syringe ndash ldquoclosed (sterile) techniquerdquo
SVF PROCUREMENT TAKES 80 MINUTES
Stemprogenitor cells
Direct injections into affected arthritic joints
Injection into difficult areas via fluoroscopy
Intravenous injection to affect systemic changes
Injection into spinal fluid or other remote areas
Directly into arteries of body or brain
Directly into soft tissues showing damage
SVF IS REGENERATIVE
SVF IS ANTI-INFLAMMATORY
SVF IS IMMUNO-MODULATORY
Orthopedics
Degenerative Diseases
Cardio-Pulmonary Diseases
Autoimmune Diseases
Urology
Neurology
Cosmetic Surgery
Spinal disk Arthritis and Chronic back or neck pain
Ankle
Hip
Knee
Tendons Ligaments Sports Injuries
Elbow Wrist
Shoulder
Prior to SVF deployment4 months after SVF deployment
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Can turn into any type of tissue in the whole body
Moral andor ethical issues
Derived from human embryos aborted or left over
from In Vitro Fertilization
Different DNA from host
Can form tumor cells (teratomas)
Found all over the body
Bone marrow produces continual flow of ldquomesenchymalrdquo stem cells
Fat has abundant source of mesenchymal stem cells
Multi-potent
No moral or ethical issue
Can Form BoneCartilageMuscleNerve tissue Blood vesselsConnective tissue Fat
Polypetide (protein) signaling molecules
Bone marrow (120000 cells)
Fat (aka adipose derived regenerative stem cells)
Others (cord organs)-low numbers
Mesenchyme stem cells decline with age
ALLOGENEIC- other humans
AUTOLOGOUS- (comes from your own body) so has same DNA as host and canrsquot be rejected lower risk of bacterial or viral infection
Dormant if no tissue damage or injury
They respond to tissue injury inflammation
degeneration or cell death
Tissue damage-homing properties
Cells may turn into needed tissue
Cells may provide messaging through Growth
Factors (eg cytokines) to repair damaged cells
Stem cell BIOAVAILABILITY- dormant cells
made available to damaged tissue
When additional stem cells are added to injured
areas in large numbers they can effect therapeutic
changes
Can exert local and systemic changes
New equipment and enzymes
Adipose (fat) derived stem cells are easy to harvest
Safe ndash under local anesthesia
Safe ndash Autologous (your own cells)
Abundant numbers of cells
Procedure takes 3 hours total
PART OF FAT RICH IN ADULT MESENCHYMAL STEM CELLS AND NATURAL GROWTH FACTORS
WHAT WE DEPLOY AT CALIFORNIA STEM CELL TREATMENT CENTERreg
Harvest fat under local anesthesia
Centrifuge to concentrate the fat
Add an enzyme to digest collagen tissue that binds
fat cells and stem cells
Remove stem cells (stromal vascular fraction) from bottom of syringe ndash ldquoclosed (sterile) techniquerdquo
SVF PROCUREMENT TAKES 80 MINUTES
Stemprogenitor cells
Direct injections into affected arthritic joints
Injection into difficult areas via fluoroscopy
Intravenous injection to affect systemic changes
Injection into spinal fluid or other remote areas
Directly into arteries of body or brain
Directly into soft tissues showing damage
SVF IS REGENERATIVE
SVF IS ANTI-INFLAMMATORY
SVF IS IMMUNO-MODULATORY
Orthopedics
Degenerative Diseases
Cardio-Pulmonary Diseases
Autoimmune Diseases
Urology
Neurology
Cosmetic Surgery
Spinal disk Arthritis and Chronic back or neck pain
Ankle
Hip
Knee
Tendons Ligaments Sports Injuries
Elbow Wrist
Shoulder
Prior to SVF deployment4 months after SVF deployment
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Found all over the body
Bone marrow produces continual flow of ldquomesenchymalrdquo stem cells
Fat has abundant source of mesenchymal stem cells
Multi-potent
No moral or ethical issue
Can Form BoneCartilageMuscleNerve tissue Blood vesselsConnective tissue Fat
Polypetide (protein) signaling molecules
Bone marrow (120000 cells)
Fat (aka adipose derived regenerative stem cells)
Others (cord organs)-low numbers
Mesenchyme stem cells decline with age
ALLOGENEIC- other humans
AUTOLOGOUS- (comes from your own body) so has same DNA as host and canrsquot be rejected lower risk of bacterial or viral infection
Dormant if no tissue damage or injury
They respond to tissue injury inflammation
degeneration or cell death
Tissue damage-homing properties
Cells may turn into needed tissue
Cells may provide messaging through Growth
Factors (eg cytokines) to repair damaged cells
Stem cell BIOAVAILABILITY- dormant cells
made available to damaged tissue
When additional stem cells are added to injured
areas in large numbers they can effect therapeutic
changes
Can exert local and systemic changes
New equipment and enzymes
Adipose (fat) derived stem cells are easy to harvest
Safe ndash under local anesthesia
Safe ndash Autologous (your own cells)
Abundant numbers of cells
Procedure takes 3 hours total
PART OF FAT RICH IN ADULT MESENCHYMAL STEM CELLS AND NATURAL GROWTH FACTORS
WHAT WE DEPLOY AT CALIFORNIA STEM CELL TREATMENT CENTERreg
Harvest fat under local anesthesia
Centrifuge to concentrate the fat
Add an enzyme to digest collagen tissue that binds
fat cells and stem cells
Remove stem cells (stromal vascular fraction) from bottom of syringe ndash ldquoclosed (sterile) techniquerdquo
SVF PROCUREMENT TAKES 80 MINUTES
Stemprogenitor cells
Direct injections into affected arthritic joints
Injection into difficult areas via fluoroscopy
Intravenous injection to affect systemic changes
Injection into spinal fluid or other remote areas
Directly into arteries of body or brain
Directly into soft tissues showing damage
SVF IS REGENERATIVE
SVF IS ANTI-INFLAMMATORY
SVF IS IMMUNO-MODULATORY
Orthopedics
Degenerative Diseases
Cardio-Pulmonary Diseases
Autoimmune Diseases
Urology
Neurology
Cosmetic Surgery
Spinal disk Arthritis and Chronic back or neck pain
Ankle
Hip
Knee
Tendons Ligaments Sports Injuries
Elbow Wrist
Shoulder
Prior to SVF deployment4 months after SVF deployment
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Can Form BoneCartilageMuscleNerve tissue Blood vesselsConnective tissue Fat
Polypetide (protein) signaling molecules
Bone marrow (120000 cells)
Fat (aka adipose derived regenerative stem cells)
Others (cord organs)-low numbers
Mesenchyme stem cells decline with age
ALLOGENEIC- other humans
AUTOLOGOUS- (comes from your own body) so has same DNA as host and canrsquot be rejected lower risk of bacterial or viral infection
Dormant if no tissue damage or injury
They respond to tissue injury inflammation
degeneration or cell death
Tissue damage-homing properties
Cells may turn into needed tissue
Cells may provide messaging through Growth
Factors (eg cytokines) to repair damaged cells
Stem cell BIOAVAILABILITY- dormant cells
made available to damaged tissue
When additional stem cells are added to injured
areas in large numbers they can effect therapeutic
changes
Can exert local and systemic changes
New equipment and enzymes
Adipose (fat) derived stem cells are easy to harvest
Safe ndash under local anesthesia
Safe ndash Autologous (your own cells)
Abundant numbers of cells
Procedure takes 3 hours total
PART OF FAT RICH IN ADULT MESENCHYMAL STEM CELLS AND NATURAL GROWTH FACTORS
WHAT WE DEPLOY AT CALIFORNIA STEM CELL TREATMENT CENTERreg
Harvest fat under local anesthesia
Centrifuge to concentrate the fat
Add an enzyme to digest collagen tissue that binds
fat cells and stem cells
Remove stem cells (stromal vascular fraction) from bottom of syringe ndash ldquoclosed (sterile) techniquerdquo
SVF PROCUREMENT TAKES 80 MINUTES
Stemprogenitor cells
Direct injections into affected arthritic joints
Injection into difficult areas via fluoroscopy
Intravenous injection to affect systemic changes
Injection into spinal fluid or other remote areas
Directly into arteries of body or brain
Directly into soft tissues showing damage
SVF IS REGENERATIVE
SVF IS ANTI-INFLAMMATORY
SVF IS IMMUNO-MODULATORY
Orthopedics
Degenerative Diseases
Cardio-Pulmonary Diseases
Autoimmune Diseases
Urology
Neurology
Cosmetic Surgery
Spinal disk Arthritis and Chronic back or neck pain
Ankle
Hip
Knee
Tendons Ligaments Sports Injuries
Elbow Wrist
Shoulder
Prior to SVF deployment4 months after SVF deployment
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Polypetide (protein) signaling molecules
Bone marrow (120000 cells)
Fat (aka adipose derived regenerative stem cells)
Others (cord organs)-low numbers
Mesenchyme stem cells decline with age
ALLOGENEIC- other humans
AUTOLOGOUS- (comes from your own body) so has same DNA as host and canrsquot be rejected lower risk of bacterial or viral infection
Dormant if no tissue damage or injury
They respond to tissue injury inflammation
degeneration or cell death
Tissue damage-homing properties
Cells may turn into needed tissue
Cells may provide messaging through Growth
Factors (eg cytokines) to repair damaged cells
Stem cell BIOAVAILABILITY- dormant cells
made available to damaged tissue
When additional stem cells are added to injured
areas in large numbers they can effect therapeutic
changes
Can exert local and systemic changes
New equipment and enzymes
Adipose (fat) derived stem cells are easy to harvest
Safe ndash under local anesthesia
Safe ndash Autologous (your own cells)
Abundant numbers of cells
Procedure takes 3 hours total
PART OF FAT RICH IN ADULT MESENCHYMAL STEM CELLS AND NATURAL GROWTH FACTORS
WHAT WE DEPLOY AT CALIFORNIA STEM CELL TREATMENT CENTERreg
Harvest fat under local anesthesia
Centrifuge to concentrate the fat
Add an enzyme to digest collagen tissue that binds
fat cells and stem cells
Remove stem cells (stromal vascular fraction) from bottom of syringe ndash ldquoclosed (sterile) techniquerdquo
SVF PROCUREMENT TAKES 80 MINUTES
Stemprogenitor cells
Direct injections into affected arthritic joints
Injection into difficult areas via fluoroscopy
Intravenous injection to affect systemic changes
Injection into spinal fluid or other remote areas
Directly into arteries of body or brain
Directly into soft tissues showing damage
SVF IS REGENERATIVE
SVF IS ANTI-INFLAMMATORY
SVF IS IMMUNO-MODULATORY
Orthopedics
Degenerative Diseases
Cardio-Pulmonary Diseases
Autoimmune Diseases
Urology
Neurology
Cosmetic Surgery
Spinal disk Arthritis and Chronic back or neck pain
Ankle
Hip
Knee
Tendons Ligaments Sports Injuries
Elbow Wrist
Shoulder
Prior to SVF deployment4 months after SVF deployment
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Bone marrow (120000 cells)
Fat (aka adipose derived regenerative stem cells)
Others (cord organs)-low numbers
Mesenchyme stem cells decline with age
ALLOGENEIC- other humans
AUTOLOGOUS- (comes from your own body) so has same DNA as host and canrsquot be rejected lower risk of bacterial or viral infection
Dormant if no tissue damage or injury
They respond to tissue injury inflammation
degeneration or cell death
Tissue damage-homing properties
Cells may turn into needed tissue
Cells may provide messaging through Growth
Factors (eg cytokines) to repair damaged cells
Stem cell BIOAVAILABILITY- dormant cells
made available to damaged tissue
When additional stem cells are added to injured
areas in large numbers they can effect therapeutic
changes
Can exert local and systemic changes
New equipment and enzymes
Adipose (fat) derived stem cells are easy to harvest
Safe ndash under local anesthesia
Safe ndash Autologous (your own cells)
Abundant numbers of cells
Procedure takes 3 hours total
PART OF FAT RICH IN ADULT MESENCHYMAL STEM CELLS AND NATURAL GROWTH FACTORS
WHAT WE DEPLOY AT CALIFORNIA STEM CELL TREATMENT CENTERreg
Harvest fat under local anesthesia
Centrifuge to concentrate the fat
Add an enzyme to digest collagen tissue that binds
fat cells and stem cells
Remove stem cells (stromal vascular fraction) from bottom of syringe ndash ldquoclosed (sterile) techniquerdquo
SVF PROCUREMENT TAKES 80 MINUTES
Stemprogenitor cells
Direct injections into affected arthritic joints
Injection into difficult areas via fluoroscopy
Intravenous injection to affect systemic changes
Injection into spinal fluid or other remote areas
Directly into arteries of body or brain
Directly into soft tissues showing damage
SVF IS REGENERATIVE
SVF IS ANTI-INFLAMMATORY
SVF IS IMMUNO-MODULATORY
Orthopedics
Degenerative Diseases
Cardio-Pulmonary Diseases
Autoimmune Diseases
Urology
Neurology
Cosmetic Surgery
Spinal disk Arthritis and Chronic back or neck pain
Ankle
Hip
Knee
Tendons Ligaments Sports Injuries
Elbow Wrist
Shoulder
Prior to SVF deployment4 months after SVF deployment
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Mesenchyme stem cells decline with age
ALLOGENEIC- other humans
AUTOLOGOUS- (comes from your own body) so has same DNA as host and canrsquot be rejected lower risk of bacterial or viral infection
Dormant if no tissue damage or injury
They respond to tissue injury inflammation
degeneration or cell death
Tissue damage-homing properties
Cells may turn into needed tissue
Cells may provide messaging through Growth
Factors (eg cytokines) to repair damaged cells
Stem cell BIOAVAILABILITY- dormant cells
made available to damaged tissue
When additional stem cells are added to injured
areas in large numbers they can effect therapeutic
changes
Can exert local and systemic changes
New equipment and enzymes
Adipose (fat) derived stem cells are easy to harvest
Safe ndash under local anesthesia
Safe ndash Autologous (your own cells)
Abundant numbers of cells
Procedure takes 3 hours total
PART OF FAT RICH IN ADULT MESENCHYMAL STEM CELLS AND NATURAL GROWTH FACTORS
WHAT WE DEPLOY AT CALIFORNIA STEM CELL TREATMENT CENTERreg
Harvest fat under local anesthesia
Centrifuge to concentrate the fat
Add an enzyme to digest collagen tissue that binds
fat cells and stem cells
Remove stem cells (stromal vascular fraction) from bottom of syringe ndash ldquoclosed (sterile) techniquerdquo
SVF PROCUREMENT TAKES 80 MINUTES
Stemprogenitor cells
Direct injections into affected arthritic joints
Injection into difficult areas via fluoroscopy
Intravenous injection to affect systemic changes
Injection into spinal fluid or other remote areas
Directly into arteries of body or brain
Directly into soft tissues showing damage
SVF IS REGENERATIVE
SVF IS ANTI-INFLAMMATORY
SVF IS IMMUNO-MODULATORY
Orthopedics
Degenerative Diseases
Cardio-Pulmonary Diseases
Autoimmune Diseases
Urology
Neurology
Cosmetic Surgery
Spinal disk Arthritis and Chronic back or neck pain
Ankle
Hip
Knee
Tendons Ligaments Sports Injuries
Elbow Wrist
Shoulder
Prior to SVF deployment4 months after SVF deployment
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
ALLOGENEIC- other humans
AUTOLOGOUS- (comes from your own body) so has same DNA as host and canrsquot be rejected lower risk of bacterial or viral infection
Dormant if no tissue damage or injury
They respond to tissue injury inflammation
degeneration or cell death
Tissue damage-homing properties
Cells may turn into needed tissue
Cells may provide messaging through Growth
Factors (eg cytokines) to repair damaged cells
Stem cell BIOAVAILABILITY- dormant cells
made available to damaged tissue
When additional stem cells are added to injured
areas in large numbers they can effect therapeutic
changes
Can exert local and systemic changes
New equipment and enzymes
Adipose (fat) derived stem cells are easy to harvest
Safe ndash under local anesthesia
Safe ndash Autologous (your own cells)
Abundant numbers of cells
Procedure takes 3 hours total
PART OF FAT RICH IN ADULT MESENCHYMAL STEM CELLS AND NATURAL GROWTH FACTORS
WHAT WE DEPLOY AT CALIFORNIA STEM CELL TREATMENT CENTERreg
Harvest fat under local anesthesia
Centrifuge to concentrate the fat
Add an enzyme to digest collagen tissue that binds
fat cells and stem cells
Remove stem cells (stromal vascular fraction) from bottom of syringe ndash ldquoclosed (sterile) techniquerdquo
SVF PROCUREMENT TAKES 80 MINUTES
Stemprogenitor cells
Direct injections into affected arthritic joints
Injection into difficult areas via fluoroscopy
Intravenous injection to affect systemic changes
Injection into spinal fluid or other remote areas
Directly into arteries of body or brain
Directly into soft tissues showing damage
SVF IS REGENERATIVE
SVF IS ANTI-INFLAMMATORY
SVF IS IMMUNO-MODULATORY
Orthopedics
Degenerative Diseases
Cardio-Pulmonary Diseases
Autoimmune Diseases
Urology
Neurology
Cosmetic Surgery
Spinal disk Arthritis and Chronic back or neck pain
Ankle
Hip
Knee
Tendons Ligaments Sports Injuries
Elbow Wrist
Shoulder
Prior to SVF deployment4 months after SVF deployment
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Dormant if no tissue damage or injury
They respond to tissue injury inflammation
degeneration or cell death
Tissue damage-homing properties
Cells may turn into needed tissue
Cells may provide messaging through Growth
Factors (eg cytokines) to repair damaged cells
Stem cell BIOAVAILABILITY- dormant cells
made available to damaged tissue
When additional stem cells are added to injured
areas in large numbers they can effect therapeutic
changes
Can exert local and systemic changes
New equipment and enzymes
Adipose (fat) derived stem cells are easy to harvest
Safe ndash under local anesthesia
Safe ndash Autologous (your own cells)
Abundant numbers of cells
Procedure takes 3 hours total
PART OF FAT RICH IN ADULT MESENCHYMAL STEM CELLS AND NATURAL GROWTH FACTORS
WHAT WE DEPLOY AT CALIFORNIA STEM CELL TREATMENT CENTERreg
Harvest fat under local anesthesia
Centrifuge to concentrate the fat
Add an enzyme to digest collagen tissue that binds
fat cells and stem cells
Remove stem cells (stromal vascular fraction) from bottom of syringe ndash ldquoclosed (sterile) techniquerdquo
SVF PROCUREMENT TAKES 80 MINUTES
Stemprogenitor cells
Direct injections into affected arthritic joints
Injection into difficult areas via fluoroscopy
Intravenous injection to affect systemic changes
Injection into spinal fluid or other remote areas
Directly into arteries of body or brain
Directly into soft tissues showing damage
SVF IS REGENERATIVE
SVF IS ANTI-INFLAMMATORY
SVF IS IMMUNO-MODULATORY
Orthopedics
Degenerative Diseases
Cardio-Pulmonary Diseases
Autoimmune Diseases
Urology
Neurology
Cosmetic Surgery
Spinal disk Arthritis and Chronic back or neck pain
Ankle
Hip
Knee
Tendons Ligaments Sports Injuries
Elbow Wrist
Shoulder
Prior to SVF deployment4 months after SVF deployment
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Stem cell BIOAVAILABILITY- dormant cells
made available to damaged tissue
When additional stem cells are added to injured
areas in large numbers they can effect therapeutic
changes
Can exert local and systemic changes
New equipment and enzymes
Adipose (fat) derived stem cells are easy to harvest
Safe ndash under local anesthesia
Safe ndash Autologous (your own cells)
Abundant numbers of cells
Procedure takes 3 hours total
PART OF FAT RICH IN ADULT MESENCHYMAL STEM CELLS AND NATURAL GROWTH FACTORS
WHAT WE DEPLOY AT CALIFORNIA STEM CELL TREATMENT CENTERreg
Harvest fat under local anesthesia
Centrifuge to concentrate the fat
Add an enzyme to digest collagen tissue that binds
fat cells and stem cells
Remove stem cells (stromal vascular fraction) from bottom of syringe ndash ldquoclosed (sterile) techniquerdquo
SVF PROCUREMENT TAKES 80 MINUTES
Stemprogenitor cells
Direct injections into affected arthritic joints
Injection into difficult areas via fluoroscopy
Intravenous injection to affect systemic changes
Injection into spinal fluid or other remote areas
Directly into arteries of body or brain
Directly into soft tissues showing damage
SVF IS REGENERATIVE
SVF IS ANTI-INFLAMMATORY
SVF IS IMMUNO-MODULATORY
Orthopedics
Degenerative Diseases
Cardio-Pulmonary Diseases
Autoimmune Diseases
Urology
Neurology
Cosmetic Surgery
Spinal disk Arthritis and Chronic back or neck pain
Ankle
Hip
Knee
Tendons Ligaments Sports Injuries
Elbow Wrist
Shoulder
Prior to SVF deployment4 months after SVF deployment
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
New equipment and enzymes
Adipose (fat) derived stem cells are easy to harvest
Safe ndash under local anesthesia
Safe ndash Autologous (your own cells)
Abundant numbers of cells
Procedure takes 3 hours total
PART OF FAT RICH IN ADULT MESENCHYMAL STEM CELLS AND NATURAL GROWTH FACTORS
WHAT WE DEPLOY AT CALIFORNIA STEM CELL TREATMENT CENTERreg
Harvest fat under local anesthesia
Centrifuge to concentrate the fat
Add an enzyme to digest collagen tissue that binds
fat cells and stem cells
Remove stem cells (stromal vascular fraction) from bottom of syringe ndash ldquoclosed (sterile) techniquerdquo
SVF PROCUREMENT TAKES 80 MINUTES
Stemprogenitor cells
Direct injections into affected arthritic joints
Injection into difficult areas via fluoroscopy
Intravenous injection to affect systemic changes
Injection into spinal fluid or other remote areas
Directly into arteries of body or brain
Directly into soft tissues showing damage
SVF IS REGENERATIVE
SVF IS ANTI-INFLAMMATORY
SVF IS IMMUNO-MODULATORY
Orthopedics
Degenerative Diseases
Cardio-Pulmonary Diseases
Autoimmune Diseases
Urology
Neurology
Cosmetic Surgery
Spinal disk Arthritis and Chronic back or neck pain
Ankle
Hip
Knee
Tendons Ligaments Sports Injuries
Elbow Wrist
Shoulder
Prior to SVF deployment4 months after SVF deployment
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
PART OF FAT RICH IN ADULT MESENCHYMAL STEM CELLS AND NATURAL GROWTH FACTORS
WHAT WE DEPLOY AT CALIFORNIA STEM CELL TREATMENT CENTERreg
Harvest fat under local anesthesia
Centrifuge to concentrate the fat
Add an enzyme to digest collagen tissue that binds
fat cells and stem cells
Remove stem cells (stromal vascular fraction) from bottom of syringe ndash ldquoclosed (sterile) techniquerdquo
SVF PROCUREMENT TAKES 80 MINUTES
Stemprogenitor cells
Direct injections into affected arthritic joints
Injection into difficult areas via fluoroscopy
Intravenous injection to affect systemic changes
Injection into spinal fluid or other remote areas
Directly into arteries of body or brain
Directly into soft tissues showing damage
SVF IS REGENERATIVE
SVF IS ANTI-INFLAMMATORY
SVF IS IMMUNO-MODULATORY
Orthopedics
Degenerative Diseases
Cardio-Pulmonary Diseases
Autoimmune Diseases
Urology
Neurology
Cosmetic Surgery
Spinal disk Arthritis and Chronic back or neck pain
Ankle
Hip
Knee
Tendons Ligaments Sports Injuries
Elbow Wrist
Shoulder
Prior to SVF deployment4 months after SVF deployment
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Harvest fat under local anesthesia
Centrifuge to concentrate the fat
Add an enzyme to digest collagen tissue that binds
fat cells and stem cells
Remove stem cells (stromal vascular fraction) from bottom of syringe ndash ldquoclosed (sterile) techniquerdquo
SVF PROCUREMENT TAKES 80 MINUTES
Stemprogenitor cells
Direct injections into affected arthritic joints
Injection into difficult areas via fluoroscopy
Intravenous injection to affect systemic changes
Injection into spinal fluid or other remote areas
Directly into arteries of body or brain
Directly into soft tissues showing damage
SVF IS REGENERATIVE
SVF IS ANTI-INFLAMMATORY
SVF IS IMMUNO-MODULATORY
Orthopedics
Degenerative Diseases
Cardio-Pulmonary Diseases
Autoimmune Diseases
Urology
Neurology
Cosmetic Surgery
Spinal disk Arthritis and Chronic back or neck pain
Ankle
Hip
Knee
Tendons Ligaments Sports Injuries
Elbow Wrist
Shoulder
Prior to SVF deployment4 months after SVF deployment
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
SVF PROCUREMENT TAKES 80 MINUTES
Stemprogenitor cells
Direct injections into affected arthritic joints
Injection into difficult areas via fluoroscopy
Intravenous injection to affect systemic changes
Injection into spinal fluid or other remote areas
Directly into arteries of body or brain
Directly into soft tissues showing damage
SVF IS REGENERATIVE
SVF IS ANTI-INFLAMMATORY
SVF IS IMMUNO-MODULATORY
Orthopedics
Degenerative Diseases
Cardio-Pulmonary Diseases
Autoimmune Diseases
Urology
Neurology
Cosmetic Surgery
Spinal disk Arthritis and Chronic back or neck pain
Ankle
Hip
Knee
Tendons Ligaments Sports Injuries
Elbow Wrist
Shoulder
Prior to SVF deployment4 months after SVF deployment
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Stemprogenitor cells
Direct injections into affected arthritic joints
Injection into difficult areas via fluoroscopy
Intravenous injection to affect systemic changes
Injection into spinal fluid or other remote areas
Directly into arteries of body or brain
Directly into soft tissues showing damage
SVF IS REGENERATIVE
SVF IS ANTI-INFLAMMATORY
SVF IS IMMUNO-MODULATORY
Orthopedics
Degenerative Diseases
Cardio-Pulmonary Diseases
Autoimmune Diseases
Urology
Neurology
Cosmetic Surgery
Spinal disk Arthritis and Chronic back or neck pain
Ankle
Hip
Knee
Tendons Ligaments Sports Injuries
Elbow Wrist
Shoulder
Prior to SVF deployment4 months after SVF deployment
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Direct injections into affected arthritic joints
Injection into difficult areas via fluoroscopy
Intravenous injection to affect systemic changes
Injection into spinal fluid or other remote areas
Directly into arteries of body or brain
Directly into soft tissues showing damage
SVF IS REGENERATIVE
SVF IS ANTI-INFLAMMATORY
SVF IS IMMUNO-MODULATORY
Orthopedics
Degenerative Diseases
Cardio-Pulmonary Diseases
Autoimmune Diseases
Urology
Neurology
Cosmetic Surgery
Spinal disk Arthritis and Chronic back or neck pain
Ankle
Hip
Knee
Tendons Ligaments Sports Injuries
Elbow Wrist
Shoulder
Prior to SVF deployment4 months after SVF deployment
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
SVF IS REGENERATIVE
SVF IS ANTI-INFLAMMATORY
SVF IS IMMUNO-MODULATORY
Orthopedics
Degenerative Diseases
Cardio-Pulmonary Diseases
Autoimmune Diseases
Urology
Neurology
Cosmetic Surgery
Spinal disk Arthritis and Chronic back or neck pain
Ankle
Hip
Knee
Tendons Ligaments Sports Injuries
Elbow Wrist
Shoulder
Prior to SVF deployment4 months after SVF deployment
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Orthopedics
Degenerative Diseases
Cardio-Pulmonary Diseases
Autoimmune Diseases
Urology
Neurology
Cosmetic Surgery
Spinal disk Arthritis and Chronic back or neck pain
Ankle
Hip
Knee
Tendons Ligaments Sports Injuries
Elbow Wrist
Shoulder
Prior to SVF deployment4 months after SVF deployment
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Spinal disk Arthritis and Chronic back or neck pain
Ankle
Hip
Knee
Tendons Ligaments Sports Injuries
Elbow Wrist
Shoulder
Prior to SVF deployment4 months after SVF deployment
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Prior to SVF deployment4 months after SVF deployment
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
End Stage CHF
Ischemic Cardiomyopathy
Acute MI
AsthmaRestrictive Lung Disease
COPDEMPHYSEMA
Not Pulmonary Fibrosis
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
FIBROMYALGIA
SCLERODERMA
POLYCHONDITIS
CIDP
MYASTHENIA GRAVIS
RHEUMATOID ARTHRITIS
CROHNS DISEASE
AUTO-IMMUNE HEPATITIS
RELAPSING POLYCHONDRITIS
ALOPECIA AREATA
OPTIC NEURITIS
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Interstitial Cystitis
Peyronies Disease
Post prostatectomy Incontinence
Erectile Dysfunction
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Int J Urol 2010 Oct17(10)896
Yamamoto T Gotoh M Hattori R Toriyama K Kamei Y Iwaguro H Matsukawa Y Funahashi Y
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy report of two initial cases
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
2006
130 (45 men and 85 women with leakage)
Myoblasts (muscle stem cells) used
111 cured 17 more improved
Males 73 improved
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Ultrasonography and magnetic resonance imaging showed sustained presence of the injected adipose tissue
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Enhanced ultrasonography showed a progressive increase in the blood flow to the injected area
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Japanese protocol
Sphincteric injection of fat and SVF into muscle
Injected through scope under local anesthesia
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Parkinsonrsquos
Multiple Sclerosis
Muscular Dystrophy
Neuropathy
Alzheimerrsquos and Mild Cognitive Impairment
Stroke Recovery and Brain Injury
Partial Spinal Cord Injuries
ALS
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Retinitis pigmentosa
Age related- dry type- Macular Degeneration
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Fortify fat grafts for better survival Face breasts buttocks hands etc
May be able to treat and improve skin quality
May be able to delay aging by adding to existing
fat
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
SVF alone
SVF with Neograft follicle transfer hair transplantation
Neograft alone
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
By far the most common type of hair restoration procedure
Involves surgery to the back of the scalp that results in a large scar
The scar will be visible with short hair Significant downtime and pain Typically good results
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
CRITICAL LIMB ISCHEMIA
WOUND CARE
TMJ SYNDROME
LICHEN SCLEROSIS
ANTI-AGEING
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Over 300 cases with one complication
No documented cases of serious injury in human
or animals
International Stem Cell Society (ISCS) ndash reported
over 1000 registered cases Less than 2 complications of any kind
No serious adverse events
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Depends on condition being treated
In 2013- we can cryopreserve cells for future use
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Active Cancer
Infection
Blood Thinners
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Use patients own cells
Provide service during same operative procedure
Minimally manipulate cells
Do not promote therapy or make claims
Performed as a surgical procedure (no laboratory)
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Need IRB approved (FDA registered) studies to
support valid claims
International Centers (variably reputable)
Research meetings
Anecdotal and testimonial information
Early results from clinical trials
Veterinary literature
Personal experience with our own patients in USA
(more than 300)
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
UNIVERSITYPHARMA LABS
FDA APPROVED TRIALS
MOSTLY BONE MARROW AND
SOME EMBRYONIC
LONG TIME FOR OUTCOMES
PATENT ISSUES
FOR INSTITUTIONAL
PROFITGOVT FUNDED
DRUG MODEL
GRASSROOTS COMMUNITY
PHYSICIANrsquoS PRACTICE
BONE MARROW AND ADIPOSE
DERIVED
RAPID CLINICAL EVALUATION
WIDESPREAD AVAILABILITY
NO PATENTS NEEDED
FOR PROFITPATIENT FUNDED
NOT ldquoDRUG ORIENTEDrdquo
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
CSN In Association with theCalifornia Stem Cell Treatment Center
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
International research sharing protocols and database including Asia and Canada
High numbers of fresh autologous cells for various degenerative conditions
Standardized Multispecialty care
Advanced deployment methods
Quality Stem Cell Therapy should be available everywhere and easily accessible
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
WWWSTEMCELLREVOLUTIONCOM
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
After Three Months
Wanted to share with you the news
I was just released from my eye therapy
I am still waiting on the prism sticker for
my glasses but no more eye patch
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
After Four Months
I am doing GREAT I have full
vision back and havenrsquot taken my
MS shots since January
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
After Five Months
This is one Happy Girl
Just left my neurologist and no signs of MS for this Girl
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention
Indiana Stem Cell Treatment CenterDr Robert F Jackson amp Dr Chris Lowery
9660 East 146th Street Suite 100
Noblesville IN 46060
317-773-6677 or 800-708-2462
wwwindianastemcelltreatmentcentercom
Thank you for your Attention